{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/121427"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/121427","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"ML-assisted therapeutics for neurodegenerative disorders","abstract":"Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-12-04 without embargo terms","abstract_html":"Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-12-04 without embargo terms","abstract_has_math":false,"creators":["Dadu, Anant"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Computer Science","degree_department":null,"school":null,"contributors":["Campbell, Roy H.","Sun, Jimeng","Do, Minh N.","Nalls, Mike","Faghri, Faraz"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-08","date_published":"2023-08","updated_at":"2026-07-22T22:24:57Z","subjects":["Machine Learning","Neurodegenerative Diseases"],"languages":["en","eng"],"rights":["Copyright 2023 Anant Dadu"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2142/121427","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Campbell, Roy H.","Sun, Jimeng","Do, Minh N.","Nalls, Mike","Faghri, Faraz"]},{"key":"dc:creator","label":"Author","values":["Dadu, Anant"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-08","2023-06-23"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Computer Science"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Machine Learning","Neurodegenerative Diseases"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en","eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2023 Anant Dadu"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2142/121427"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-12-04 without embargo terms","The student, Anant Dadu, accepted the attached license on 2023-06-22 at 14:59.","The student, Anant Dadu, submitted this Dissertation for approval on 2023-06-22 at 15:04.","This Dissertation was approved for publication on 2023-06-23 at 16:40.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19451 on 2023-12-04 at 17:00:08","Neurodegenerative disorders (NDDs) are a significant public health issue, affecting 50 million people worldwide every year. The complexity of NDDs hinders progress in the development of prevention and disease-modifying therapies. Despite numerous clinical trials, the success rate for treating the condition remains less than 1\\%, with many trials failing at the late stage leading to significant financial burden and negative outcomes. Challenges presented by NDDs include disease heterogeneity, overlapping clinical syndromes, a long asymptomatic phase, and incomplete understanding of disease mechanisms. A more systematic and efficient approach to the causes and diagnosis of these diseases is needed to accelerate the growth of effective treatments and ultimately improve health outcomes. In the current research landscape, there has been a remarkable upsurge in real-world datasets dedicated to NDDs, characterized by a significant expansion in both sample size and the inclusion of diverse data modalities. Leveraging machine learning techniques to analyze this data presents an exciting opportunity to address challenges presented by NDDs. We have shown that a machine learning algorithm can delineate subgroups within Parkinson’s disease by discovering hidden patterns from multi-modal symptomatic data in an unbiased way. Given the longitudinal nature of NDDs, we illustrated the use of longitudinal dimensional reduction approach to identify underlying trajectory patterns within large biomedical datasets. We demonstrated that disease probability scores obtained by exposing brain imaging and genomics data to machine learning tools are useful for risk stratification, prognosis prediction, and monitoring disease progression. Our multi-modal approach on large aggregates of real-world data, along with the contribution of our interactive data-driven web applications, leads to a substantial enhancement in transparency, reproducibility, and accessibility. We anticipate that this dissertation will have a transformative impact on industry and academia by advocating for and enabling data-driven methodologies to enhance medical research. Our comprehensive evaluation and open-source deployment of research results should reduce the friction between basic science research and its practical implementation in clinical settings or drug development processes. As research evolves and produces more complex datasets, we believe that the use of computational tools will become more prevalent in the field. Research outputs of this work can serve as a reference for future research in this area, as it showcases the potential of machine learning to assist medical research for neurodegenerative disorders."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["ML-assisted therapeutics for neurodegenerative disorders"]}]}],"canonical_facts":{"dc:contributor":["Campbell, Roy H.","Sun, Jimeng","Do, Minh N.","Nalls, Mike","Faghri, Faraz"],"dc:creator":["Dadu, Anant"],"dc:date":["2023-08","2023-06-23"],"dc:description":["Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2023-12-04 without embargo terms","The student, Anant Dadu, accepted the attached license on 2023-06-22 at 14:59.","The student, Anant Dadu, submitted this Dissertation for approval on 2023-06-22 at 15:04.","This Dissertation was approved for publication on 2023-06-23 at 16:40.","DSpace SAF Submission Ingestion Package generated from Vireo submission #19451 on 2023-12-04 at 17:00:08","Neurodegenerative disorders (NDDs) are a significant public health issue, affecting 50 million people worldwide every year. The complexity of NDDs hinders progress in the development of prevention and disease-modifying therapies. Despite numerous clinical trials, the success rate for treating the condition remains less than 1\\%, with many trials failing at the late stage leading to significant financial burden and negative outcomes. Challenges presented by NDDs include disease heterogeneity, overlapping clinical syndromes, a long asymptomatic phase, and incomplete understanding of disease mechanisms. A more systematic and efficient approach to the causes and diagnosis of these diseases is needed to accelerate the growth of effective treatments and ultimately improve health outcomes. In the current research landscape, there has been a remarkable upsurge in real-world datasets dedicated to NDDs, characterized by a significant expansion in both sample size and the inclusion of diverse data modalities. Leveraging machine learning techniques to analyze this data presents an exciting opportunity to address challenges presented by NDDs. We have shown that a machine learning algorithm can delineate subgroups within Parkinson’s disease by discovering hidden patterns from multi-modal symptomatic data in an unbiased way. Given the longitudinal nature of NDDs, we illustrated the use of longitudinal dimensional reduction approach to identify underlying trajectory patterns within large biomedical datasets. We demonstrated that disease probability scores obtained by exposing brain imaging and genomics data to machine learning tools are useful for risk stratification, prognosis prediction, and monitoring disease progression. Our multi-modal approach on large aggregates of real-world data, along with the contribution of our interactive data-driven web applications, leads to a substantial enhancement in transparency, reproducibility, and accessibility. We anticipate that this dissertation will have a transformative impact on industry and academia by advocating for and enabling data-driven methodologies to enhance medical research. Our comprehensive evaluation and open-source deployment of research results should reduce the friction between basic science research and its practical implementation in clinical settings or drug development processes. As research evolves and produces more complex datasets, we believe that the use of computational tools will become more prevalent in the field. Research outputs of this work can serve as a reference for future research in this area, as it showcases the potential of machine learning to assist medical research for neurodegenerative disorders."],"dc:format":["application/pdf"],"dc:identifier":["https://hdl.handle.net/2142/121427"],"dc:language":["en","eng"],"dc:rights":["Copyright 2023 Anant Dadu"],"dc:subject":["Machine Learning","Neurodegenerative Diseases"],"dc:title":["ML-assisted therapeutics for neurodegenerative disorders"],"dc:type":["text"],"thesis:degree_discipline":["Computer Science"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:57Z"}